Clin2
NCT06201611Possibly a fitRecruiting

Nebivolol for diabetic nerve damage study

Diabetic Neuropathy Peripheral

Part of Brain & nervous system, Hormones & metabolism clinical trials.

This study tests whether the drug nebivolol (a type of beta-blocker) can help slow or reverse nerve damage caused by diabetes. It is for people with recent diabetes and confirmed neuropathy.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
120 people
Ages
Up to 18 years
Study type
Interventional

Who can take part

  • You are 18 or older and have had diabetes for less than 5 years.
  • Your diabetes is stable (HbA1c under 9% for the last 3 months).
  • You have nerve damage (neuropathy) from diabetes, confirmed by a nerve test.
  • You do not have a very slow heart rate, heart block, severe asthma, or COPD.
  • You are not currently taking a beta-blocker or a specific type of calcium channel blocker.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06755801Not yet recruiting· Phase 3
Nebivolol for chest pain with normal coronary arteries

This trial tests if the drug nebivolol reduces chest pain in people who have chest pain but no major blockages in their heart arteries. It looks at whether the small blood vessels in the heart are not working properly, which can cause symptoms.

NCT06603792Recruiting
Brain training for diabetic nerve pain

This study tests whether a brain training method called neurofeedback can help reduce nerve pain caused by diabetes. It may offer a new, non-drug way to manage pain.

Odense
NCT07683598Not yet recruiting
Testing a natural supplement for diabetic nerve pain

This study tests an experimental medicine called DLBS1033 (a natural supplement) added to your usual treatment for diabetic nerve pain. It aims to see if it improves symptoms and quality of life.

Medan, North Sumatera
NCT07028528Recruiting· Phase 2
Study of Levagen+ for diabetic nerve pain

This trial tests if Levagen+ (a supplement) can reduce nerve pain caused by diabetes. It is for people with type 1 or type 2 diabetes who have significant nerve pain in their feet or legs.

Fortitude Valley, Queensland
NCT06906081Recruiting· Phase 2
Finerenone for diabetic nerve damage (FibroCAN study)

This trial tests if finerenone can help people with type 2 diabetes who have early signs of nerve damage affecting their heart and blood vessels (cardiovascular autonomic neuropathy). It aims to see if the drug can improve heart rate control and reduce symptoms.

Gistrup
NCT07183761Recruiting· Phase 2
Stem cell therapy for diabetic nerve pain

This study tests whether umbilical cord stem cells can help people with diabetic nerve damage in their legs who haven't gotten enough relief from standard treatments. It aims to improve symptoms like numbness, pain, and tingling.

Chongqing, Chongqing Municipality

Hear when a new Diabetic Neuropathy Peripheral trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.